Colors: Green Color

Eisai Co., Ltd. has announced that LENVIMA (generic name: lenvatinib), the orally available kinase inhibitor discovered by Eisai, has been accepted by the National Medical Products Administration of China for an application for the additional indication of differentiated thyroid cancer. This application for additional indication marks the second in China following the indication for hepatocellular carcinoma, which was approved in September 2018.

The Ministry of Health and Prevention, MoHAP, has recently signed a memorandum of understanding with Sanofi Aventis Group and Axios Health Education Services, under which MoHAP will launch a new initiative entitled “Ea’nah” (Support) for patients with relapsing multiple sclerosis (RMS) and Relapsing-remitting MS (RRMS), patients with moderate to severe eczema (atopic dermatitis), and patients with some cases of severe asthma.

To commemorate the occasion of World Children’s Day, Medcare Hospitals & Medical Centres and Aster Volunteers joined forces with Human Appeal International, Ajman, to launch their initiative titled ‘Healthy Kids, Brighter Future’ on 22nd November 2019 at Medcare Hospital Sharjah. Under this initiative, Aster Volunteers and Medcare Hospitals hosted a fun-filled children’s’ medical camp wherein over 40 volunteers conducted health checkups for more than 350 underprivileged children.